Phase change material Market Research Report—Global Forecast till 2028

Phase change material Market Research Report Information by Type (Organic, Inorganic, Eutectic), Equipment (Refrigerators, Cold Boxes, Carriers), Temperature Range (-20 to -35 deg C, 2 to 8 deg C, 10 to 15 deg C, others), End user (Biopharmaceutical Companies, Hospitals, Medical Laboratories, Others) Forecast till 2028

ID: MRFR/CnM/6810-CR | March 2021 | Region: Global | 140 pages

Phase change material Market

The phase change material market size is projected to be worth USD 49,021.39 thousand by 2028, registering a CAGR of 17.90% during the forecast period (2021–2028)

Segmentation

By Type Organic Inorganic Eutectic
By Equipment Refrigerators Cold Boxes Carriers
By Temperature Range -20 to -35 deg C 2 to 8 deg C 10 to 15 deg C Others
By End user Biopharmaceutical Companies Hospitals Medical Laboratories Others

Key Players

  • Croda International Plc (UK)
  • Sasol (South Africa)
  • Henkel AG & Co. KGaA (Germany)
  • Cryopak (US)
  • Merck KGaA (Germany)
  • Pluss Advanced Technologies Pvt. Ltd
  • PureTemp (US)
  • Teappcm (US)
  • Rubitherm (Germany)

Drivers

  • Growing demand for pcms in drug delivery and vaccine and medicinal transport
  • Use of pcms for therapeutic hypothermia in neonatal and rheumatic diseases
Speak to Analyst Request a Free Sample

Phase Change Material Market Overview


The phase change material market size is projected to be worth USD 49,021.39 thousand by 2028, registering a CAGR of 17.90% during the forecast period (2020–2028). The market was valued at USD 13,397.69 thousand in 2020.


Phase change materials (PCMs) are substances which absorb or release large amounts of so-called 'latent' heat when they go through a change in their physical state, i.e., from solid to liquid and vice versa. Offering a range of thermal management solutions, PCMs facilitate the ability to manage demand between energy requirements and usage.


In medical sector, the PCMs are extensively used for transportation of blood, vaccines, and temperature-sensitive pharmaceuticals, operating tables, hot-cold therapies, treatment of birth asphyxia, and drug delivery.


COVID-19 Impact on the Phase change material Market:


The outbreak of COVID-19 resulted in oil price drop on account of reduced global demand for oil by about 29 thousand barrels a day from about 100 thousand a year ago. An ample supply of crude oil in the market helped synthetic chemicals and materials manufacturers secure raw materials at a lower cost, which could have been used for production of PCMs. However, with curfews, lockdown, and travel restrictions across the globe, the supply chain witnessed disruptions at every point. Due to the shutdown of many supply routes, the availability of these materials was disrupted, thus negatively impacting the market.


Additionally, the restrictions on commerce during the COVID-19 pandemic resulted in the healthcare cold chain industry's supply chain damage, thus causing cold chain manufacturers prioritizing their storage to extend shelf-life. This resulted in high demand for PCMs. Many rising countries, such as India, have insufficient cold chain capacity to meet current vaccination efforts. Furthermore, to meet the increased cold chain space necessary for the vaccine in October 2020, the Union Health Ministry launched a cold chain reinforcement plan to address the demand and supply of proper vaccine storage and management. With the ongoing COVID-19 pandemic evolving dynamically, the operational guideline is being implemented by the government and dynamic documents are being updated as per the evolving situation of the pandemic.


Market Dynamics


Drivers


  • GROWING DEMAND FOR PCMS IN DRUG DELIVERY AND VACCINE AND MEDICINAL TRANSPORT


PCMs are bio-based materials such as fatty acids or oils that are employed as a shell material for drug delivery. Phase change materials are renewable, reusable, and engine and fuel independent, making them perfect for vaccination transportation. Temperature-release medication delivery has been the focus of biotech research. The use of PCM as a "cork" is one successful technique for achieving temperature-released medication delivery.


Restraints


  • DISADVANTAGES ASSOCIATED WITH PCM PRODUCTS


PCM pallet is a flat structure containing PCM, on which products are stored when they are being transported. Certain disadvantages associated with the product are cooling effect comes from beneath the product, which creates a larger temperature gradation from the topmost products to the lower products. Such disadvantages linked with the use of PCM products is a restraint for the market growth.


Opportunity


  • INCREASING NUMBER OF CLINICAL TRIALS AND DEVELOPMENT OF NEW THERAPIES


The number of clinical trials is growing in tandem with the discovery of novel cures and medications. Cold chain logistics are required to protect the integrity of clinical trial materials such as medications, blood samples, tissue samples, urine samples, and sputum samples. Furthermore, the most promising COVID-19 vaccine candidates are designated as "cold chain" items, which necessitate special storage and shipping from the time they leave the manufacturer's facility. Henceforth, the market is predicted to provide opportunities for players engaged in the market due to the need for cold chain logistics for the storage and shipment of such vaccines and treatments


Challenge


  • REGULATIONS IN THE COLD SUPPLY CHAIN


The World Health Organization (WHO) has frame worked guidelines on the international packaging and shipping of vaccines and Codex Alimentarius, for the pharmaceutical shipping through cold chain. Furthermore, The Food and Drug Administration (FDA) in the US establishes guidelines for the manufacture, storage, and distribution of pharmaceutical and food items. This regulations are expected to be a challenge factors for several key players operating in the market


Segmentation


By Type



  • Organic

  • Inorganic

  • Eutectic


By Equipment



  • Refrigerators

  • Cold Boxes

  • Carriers


By Temperature Range



  • -20 to -35 deg C

  • 2 to 8 deg C

  • 10 to 15 deg C

  • Others


By End-user



  • Biopharmaceutical Companies

  • Hospitals

  • Medical Laboratories

  • Others


Regional Analysis


Asia-apcific accounted for the largest market share and is projected to exhibit a healthy CAGR over the forthcoming years. The growth of the region can be associated with the growth of the pharmaceutical industry in China, India, and Japan. China's healthcare industry has risen quickly, allowing it to move from a pharmaceutical manufacturing base to a vital R&D hub. As a result, China has solidified its position as a key player in the global pharmaceutical sector, both as a consumer and base for expanding R&D. Additionally, the market in North America is fueled by access to high-value drugs, vaccine transportation, healthcare awareness, high per capita expenditure on healthcare, and the high GDP of the region. In Europe, the presence of many companies and SMEs that manufacture and supply phase change materials is expected to provide optimistic growth for Europe market. Also, The European Health Union implemented a strategy in 2020, which includes a broad scope of areas such as research and development of medicines, laboratory testing, clinical trials, marketing authorization, manufacturing, health technology assessment, pricing and reimbursement, intellectual property protection, and the entry of medicines, including generics and biosimilars in the market.


Competitive Landscape


The global phase change material market is highly fragmented and consists of many organized and unorganized industry players. The key players operating in the global market have large production bases and advanced manufacturing facilities at the domestic and international levels. The global market for phase change material is anticipated to grow at a healthier CAGR during the forecast period, owing to the increasing demand from the biopharmaceuticals companies. Some of the prominent players in the global Phase change material market include Croda International Plc (UK), Sasol (South Africa), Henkel AG & Co. KGaA (Germany), Cryopak (US), Merck KGaA (Germany), Pluss Advanced Technologies Pvt. Ltd (India), PureTemp (US), Teappcm (US), Rubitherm (Germany), Cold Chain Technologies (US), and PCM Products Ltd (UK).


Report Overview:


The Phase change material market is segmented by type, equipment, temperature range, end user and region in the report. In terms of insights, this report has focused on various levels of analysis such as market dynamics, value chain analysis, Porter's five forces, competitive landscape, and company profiles—all of which comprise and discuss views on the global phase change material emerging and fast-growing segments, regions, and countries.


Objectives of the Study



  • To get a comprehensive overview of the global Phase change material market

  • To get wide-ranging information about the key factors driving the market and market opportunities

  • To gain information regarding the key players in the industry, their product portfolio, strategies, and key developments

  • To gain insights about the key country/region in which the market is growing


Intended Audience



  • Biopharmaceutical Companies

  • Hospitals

  • Medical Laboratories

  • Shipping Companies

  • Research Institutes

  • Academic Institutes

  • Government Organizations



Report Scope:
Report Attribute/Metric Details
  Market Size    2028: USD 49,021.39 thousands
  CAGR   17.90% CAGR (2021-2028)
  Base Year   2020
  Forecast Period   2021-2028
  Historical Data   2019
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type and End-use
  Geographies Covered   North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa
  Key Vendors   Croda International Plc (UK), Sasol (South Africa), Henkel AG & Co. KGaA (Germany), Cryopak (US), Merck KGaA (Germany), Pluss Advanced Technologies Pvt. Ltd (India), PureTemp (US), Teappcm (US), Rubitherm (Germany), Cold Chain Technologies (US), and PCM Products Ltd (UK)
  Key Market Opportunities   â€¢ Increasing number of clinical trials and development of new therapies
  Key Market Drivers   â€¢ Growing demand for pcms in drug delivery and vaccine and medicinal transport • Use of pcms for therapeutic hypothermia in neonatal and rheumatic diseases


Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

The global Phase change material market would register a growth of 17.90%.

The biopharmaceutical industry will play a prominent role in taking the market forward.

Disadvantages of phase change materials could restrain the market.

Asia-Pacific would enjoy the upper hand in the Phase change material market.